RT @SilverVVulpes: so again, no appreciable decline of antibodies within just a few months, and by PCR they miss less than 10% of positives…
so again, no appreciable decline of antibodies within just a few months, and by PCR they miss less than 10% of positives (https://t.co/XdUuTrMeco tables 2 and 3) still have to see any convincing evidence serology studies do an important underestimate
@FaheemYounus .@reevakhanna1 A study of over 60,000 people in Spain found 3.4% of children and teenagers had antibodies to the virus, compared with 4.4% to 6.0% of adults. But Spain’s schools were also closed, which likely reduced children’s exposure. http
Herd immunity myths busted yet or not? https://t.co/btUq88CdbL
@NotRealCertain Here’s the link https://t.co/E3u0FLYQMh
@WilsonKM2 @macroeu Except of course it hasn't. Approx 4.6% of Spain' population (2.1 million people) caught #Covid in their first wave - see Serology surveys in June Case numbers for most countries are huge underestimations in the early stages due to ver
@RebelACole @TsicsafPelosi @whelanh1 One more chart, that I suspect @RebelACole doesn't understand. He'd rather keep spreading his misinformation that covid is becoming "10 times less deadly": https://t.co/2CAugC1puI
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
@McFaul @atrupar No and a study conducted in Spain showed only 5% of their 60K test participants had antibodies in their system. This is just willfully wanting to thin out the US population. https://t.co/HdQmDeJ4yx
RT @zorinaq: @HowardSteen4 @anaxagoras484 @BallouxFrancois @MLevitt_NP2013 Very simple: the case ascertainment rate has been significantly…
https://t.co/n01wVRp8Kt https://t.co/9gtahEkpfd https://t.co/58cHF2Z58P Sources, as anyone who is not a grifter knows to provide.
@tOm_L_L Déja vu. Read these 2 threads: https://t.co/ifoA6zmud2 . https://t.co/2CAugC1puI .
@HowardSteen4 @anaxagoras484 @BallouxFrancois @MLevitt_NP2013 Very simple: the case ascertainment rate has been significantly improving. Thread below was about Spain, but the same applies to the Netherlands and Belgium: https://t.co/QAJkk2orNA
RT @zorinaq: According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —ab…
RT @Miesli2: Link naar te downloaden artikel The Lancet. https://t.co/uD3NcqvRuY Despite the high impact of COVID-19 in Spain, prevalence…
RT @Miesli2: Link naar te downloaden artikel The Lancet. https://t.co/uD3NcqvRuY Despite the high impact of COVID-19 in Spain, prevalence…
Link naar te downloaden artikel The Lancet. https://t.co/uD3NcqvRuY Despite the high impact of COVID-19 in Spain, prevalence estimates remain low and are clearly insufficient to provide herdimmunity. This cannot be achieved without accepting the collatera
@MarkReady47 @DrRichJohnston @HenryMarott @BallouxFrancois @deb_cohen This makes assumptions that are likely to produce inaccurate results. The comments at the end include a clear analysis of this problem. Some provinces in Spain had antibody prevalence a
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/wnZwjNSHhe
@Wanderingphysi1 @TomDebenham @readthinkwalk @trishgreenhalgh @Wanderingphysi1 you point is very astute illustrated below. It should be noted in Spain deaths are rising. Reality likely multifactorial - younger cohort exposes, reduced innoculum masks/distan
RT @zorinaq: According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —ab…
@FatEmperor Here you go: https://t.co/aTuLiub6HC
RT @zorinaq: According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —ab…
RT @davidwdowdy: Spain now has more COVID cases per capita than the US - concentrated in Madrid & Aragon, where seroprevalence is highest.…
RT @zorinaq: According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —ab…
RT @zorinaq: According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —ab…
@boutros555 @FatEmperor @nosmhnmh @venivici27 @FrankfurtZack @daniellevitt22 @kylamb8 @Humble_Analysis @AlistairHaimes @therealarod1984 @NahasNewman @JTUGS 3 words: case ascertainment rate You do need to read this whole thread: https://t.co/2CAugC1puI
@nosmhnmh @FatEmperor @venivici27 @FrankfurtZack @daniellevitt22 @kylamb8 @Humble_Analysis @AlistairHaimes @therealarod1984 @NahasNewman @JTUGS Spain is not done with it. Seroprevalence was only 5% in early May (after 1st wave): https://t.co/kcaeP9MV7J and
According to the ENE-COVID serosurvey, 2.4M (5.0%) of the population was infected as of early May: https://t.co/kcaeP9MV7J —about 10x more than the 220k known cases at the time Daily cases peaked 10x higher than we thought! So the small number of deaths
@SethAbramson The only thing I can think of right now is the study they did in Spain and they only found 5% of those studied had antibodies. This was a rest with over 60K participants, many who were living in hard hit areas. https://t.co/HdQmDeJ4yx
@tombyrer @rubbersoul0 @COVID19Tracking I have seen many antibody studies in the US that have suffered from similar weaknesses: too small and not truly a random sample. The best antibody study that I've seen was done in hard hit Spain, that estimated only
RT @Eviltoastman: @s0f0nisba @LuckyHeronSay The science elsewhere said similar a few months back. https://t.co/SyAPo9Xfys
@JL_MDesconocido El estudio está aquí por si lo quieren leer: https://t.co/rqUqnlg5Hg
@s0f0nisba @LuckyHeronSay The science elsewhere said similar a few months back. https://t.co/SyAPo9Xfys
@MaxCRoser Too high an estimate to fit seroprevalence data (aprox. 5.0% in May, https://t.co/Xw9CYl7Ge1). Better check model parameters to adjust to observed data
RT @davidwdowdy: Spain now has more COVID cases per capita than the US - concentrated in Madrid & Aragon, where seroprevalence is highest.…
RT @davidwdowdy: Spain now has more COVID cases per capita than the US - concentrated in Madrid & Aragon, where seroprevalence is highest.…
@davidwdowdy Even in Madrid, estimated seroprevalence was ~ 11% in May. https://t.co/24UqrzpdmI
RT @MarReanimacio: #ENE-COVID: el estudio de seroprevalencia de #COVID19 en España. Publicado en @TheLancet a principios de Julio. Ya tien…
#ENE-COVID: el estudio de seroprevalencia de #COVID19 en España. Publicado en @TheLancet a principios de Julio. Ya tiene unas semanas y es solo la foto de un momento, pero sin duda aporta a la historia de la enfermedad... https://t.co/dkaQ0LW4od https://t
RT @davidwdowdy: Spain now has more COVID cases per capita than the US - concentrated in Madrid & Aragon, where seroprevalence is highest.…
Spain now has more COVID cases per capita than the US - concentrated in Madrid & Aragon, where seroprevalence is highest. Not consistent with herd immunity. https://t.co/pZf50jEsWS https://t.co/fj8PU3hbyM https://t.co/zRr4XGJSmx https://t.co/GoyyQAmPwx
gerar ao sistema de saúde, como foi o caso da primeira estratégia sueca. Jornais científicos se quiserem ler mais: https://t.co/MXd9OIQVt3 https://t.co/chdsfa47pg https://t.co/a2RBZ2U2vi https://t.co/9i0ZvmmL7R
@GunnarBj @alexkx3 The worst hit province of Catalonia, Barcelona, was only at 6.8% seroprevalence after the spring wave: https://t.co/kcaeP9MV7J So, no it's not likely that "many of those" have already been infected. Only 6.8% chance they were. https://t
@martuniki El estudio Ene-Covid (https://t.co/efiWGbeaEi) determina en España una seroprevalencia de anticuerpos contra el SARS Cov2 de un 5% (~2,4 millones). Calculando la tasa de mortalidad (IFR) con los muertos estimados por diversos estudios (INE, MoMo
@pablonetdj ¿Qué información está sesgada? El estudio de seroprevalencia en España arrojó un 5% de infectados, aquí lo dice claro: https://t.co/E5tLNC617p Y en España llevamos 28 mil fallecidos oficiales, y ojo que el exceso de mortalidad es superior: http
@k_ben_younes @edouardadit @Conflits_FR Critères admis entrainant publication par le Lancet le 6 juillet dernier https://t.co/3mTvAqCQoK Votre étude si elle avait pu être un temps publiée dans "The Lancet" elle en est réduite aujourd'hui avec le retour du
@LucioMM1 Well the question here is what exactly the "herd immunity" thresholds are. Some good seroprevalence studies from Spain for instance—disease seemed to hit a max around 10-15% in parts of Castille. It's now still severe in Madrid, N Spain second ti
@bencorke @valplantpot @Jp60828893 @jbee_texasblue @mhdksafa @remindmetweets As I said it was a Spanish study. Funding: Spanish Ministry of Health, Institute of Health Carlos III, and Spanish National Health System. I read the study, checked references, fo
RT @zorinaq: Bottom line, the prevalence of SARS-CoV-2 in Sweden is ~6% nationwide ~10% Stockholm This is comparable to Spain (~5% nationw…
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
@AlexBerenson Your tweets are logically inconsistent. You've been claiming Sweden has reached herd immunity (which isn't true, as cases increased for 3 wks), yet Madrid has ~12% seroprevalence (more than Sweden), and cases are surging in Madrid: https://t.
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
RT @acorderofort: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Enhorabuena @Raq…
RT @acorderofort: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Enhorabuena @Raq…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @felly500: Spanish seroprevalence Seroprevalence = 4.6% Interesting differences between point of care vs immunoassay +++ geographical v…
RT @GlobalPHObserv: Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/…
Prevalence of SARS-CoV-2 in #Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/dVDAjtcQZU
RT @felly500: Spanish seroprevalence Seroprevalence = 4.6% Interesting differences between point of care vs immunoassay +++ geographical v…
RT @felly500: Spanish seroprevalence Seroprevalence = 4.6% Interesting differences between point of care vs immunoassay +++ geographical v…
Spanish seroprevalence Seroprevalence = 4.6% Interesting differences between point of care vs immunoassay +++ geographical variability, with higher prevalence around Madrid (>10%), lower in coastal areas (<3%) 33% seropositive participants asymptoma
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/gdw8W6XY3M
Gracias al esfuerzo de mucha gente en Atención Primaria sale adelante este estudio. En especial a todo el personal de enfermería. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @macips01: ...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els…
RT @DoktormedMX: La inm. de rebaño es un concepto que explica el fenómeno que se alcanza de manera activa vacunando a gente vulnerable. Pre…
...però sí que ens pot donar una pista la serologia, que diu quans nens han passat la infecció i tenen anticossos: ~3.4% els <10a (pel 4.4% dels >20a o el 5.3% dels >35a). Son xifres semblants o lleugerament inferiors. https://t.co/2mwdIzcek6 (4/1
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/mTc8Y6Mz18
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/eKlVHkdK3J
Lessons from #Spain 🇪🇸 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study @TheLancet https://t.co/daat4Bqztq
@TheLancet paper on seroprevalence in Spain. Ranging regionally from <3% to >10%. ~90% of those who had a positive PCR had a positive serologic test. Higher in healthcare. Roughly 1/3 asymptomatic, higher than the ~20% in recent systematic reviews.
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Enhorabuena @RaquelYotti por este gran trabajo!!! @CIBER_CV https://t.co/X10mBHijxd
@Marcos98285978 @benshapiro "Seroprevalence was 5·0% (95% CI 4·7–5·4) by the point-of-care test and 4·6% (4·3–5·0) by immunoassay, with a specificity–sensitivity range of 3·7% (3·3–4·0; both tests positive) to 6·2% (5·8–6·6; either test positive), with no
@Bushy82 This is the million-dollar question! How do we know the proportion of population infected, and on a relevant note, the proportion immune to the virus? Maybe this article would be of interests? https://t.co/TbWpzHXISU As it comes to our current d
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/YWazpxL6hr
RT @RiveraDommarco: En la Teleconferencia del @inspmx de hoy, la Dra. Pollán mostró que ~5% de la población española tuvo anticuerpos contr…
RT @AtomsksSanakan: Further age-specific IFR estimates: https://t.co/AzLiLO6rZn [https://t.co/8UUt3r6nKF] https://t.co/8jDjhKVyiA https:…
Further age-specific IFR estimates: https://t.co/AzLiLO6rZn [https://t.co/8UUt3r6nKF] https://t.co/8jDjhKVyiA https://t.co/jsSO0oQm19 https://t.co/HRQZ7cHLm6 [with: https://t.co/v4dXsR4GTT https://t.co/WSixjspkhg https://t.co/tct7ePjFXA] https://t.co/O
@oyanes_to @elTentacle Les seroprevalences al famós estudi espanyol a Lancet (amb n molt alta) és molt semblant a totes les edats, només lleugerament inferior en nens: https://t.co/LL7TjEZNys
RT @RiveraDommarco: En la Teleconferencia del @inspmx de hoy, la Dra. Pollán mostró que ~5% de la población española tuvo anticuerpos contr…